CAST replies

Issue: BCMJ, vol. 50, No. 1, January February 2008, Page 15 Letters
By: David C. Marsh, MD, Michael Krausz, MD,

The most effective and best-studied treatment available in addiction medicine is methadone maintenance treatment (MMT), which leads to a range of benefits for individuals with opioid dependence and society at large.[1] Unfortunately, not all those with opioid dependence benefit from MMT and there is no similar medication available for the treatment of stimulant dependence (particularly crack cocaine or crystal methamphetamine).

The Chronic Addiction Substi­tution Treatment Trials (CAST) are planned as a series of five scientifically rigorous, ethically sound clinical research studies to be conducted in Vancouver to evaluate novel pharmacological strategies for opioid and stimulant dependence. 

As Dr Mela­med and colleagues correctly state, pharmacological treatments are most effective when combined with a full range of psychosocial services such as supportive housing, social supports sufficient to prevent abject poverty, addiction counseling, psychiatric care, and primary medical care, and participants in CAST will receive this full range of services in combin­ation with the study medications. 

Throughout the trial, participants will be able to access these services regardless of whether they continue on the study medications. More importantly, for most of these services, the access will not be limited to the duration of the trials or to those who participate in CAST. For example, over the past year the municipal and provincial governments have announced several new initiatives that will significantly ex­pand access to supportive housing in Vancouver, and while CAST participants will be able to avail of these services, access will not be limited to CAST participants. 

If we insisted, as Dr Melamed and colleagues suggest, that novel medications cannot be evaluated until access to support services is available to all, then we would still be limited to treating hypertension with diuretics while working to ex­pand dietary and exercise programs.

The second misunderstanding within the letter deals with the primary goal of CAST. All the trials are designed with improved health of the participants as the primary outcome. At the same time, it is important to recognize that MMT leads to dra­matic reductions in criminal activity and any other successful substitution treatment is likely to generate similar positive outcomes for society.[2]

Clinical research can be an im­portant vehicle for improving addiction treatment through expanding the range of effective treatment options, highlighting the elements of currently available treatments which can be improved, accessing research-specific funding streams such as the Canadian Institutes of Health Research and facilitating advocacy for those who do not benefit from the present treatment options. We believe it is time those in British Columbia suffering from addiction were offered these benefits.

-David C. Marsh, MD
Co-Chair, Clinical Advisory Committee, CAST

-Michael Krausz, MD
Co-Chair, Clinical Advisory Committee, CAST

References

1. Health Canada. Best practices—Metha­done maintenance treatment. Ottawa: Health Canada, 2002.
2. Sheerin I, Green T, Sellman D, et al. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. NZ Med J 2004;117:U795.

David C. Marsh, MD,, Michael Krausz, MD,. CAST replies. BCMJ, Vol. 50, No. 1, January, February, 2008, Page(s) 15 - Letters.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply